Cas:2480-96-8 H-Orn(Boc)-Ome.HCl manufacturer & supplier

We serve Chemical Name:H-Orn(Boc)-Ome.HCl CAS:2480-96-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

H-Orn(Boc)-Ome.HCl

Chemical Name:H-Orn(Boc)-Ome.HCl
CAS.NO:2480-96-8
Synonyms:ORNITHINE(BOC)-OME HCL;Methyl (2S)-2-amino-5-[(tert-butoxycarbonyl)amino]pentanoate hydrochloride;H-Orn(Boc)-OMe;H-Orn(Boc)-OMe.HCl;(2S)-2-Amino-5-[(tert-butoxycarbonyl)amino]pentanoic acid methyl ester hydrochloride
Molecular Formula:C11H23ClN2O4
Molecular Weight:282.76400
HS Code:2924199090

Physical and Chemical Properties:
Melting point:154-155ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:90.65000
Exact Mass:282.13500
LogP:2.68480

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like ORNITHINE(BOC)-OME HCL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-2-Amino-5-[(tert-butoxycarbonyl)amino]pentanoic acid methyl ester hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl (2S)-2-amino-5-[(tert-butoxycarbonyl)amino]pentanoate hydrochloride Use and application,(2S)-2-Amino-5-[(tert-butoxycarbonyl)amino]pentanoic acid methyl ester hydrochloride technical grade,usp/ep/jp grade.


Related News: For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” H-Orn(Boc)-Ome.HCl manufacturer In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape. H-Orn(Boc)-Ome.HCl supplier For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” H-Orn(Boc)-Ome.HCl vendor Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease. H-Orn(Boc)-Ome.HCl factory Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease.